Drug Channels
Pages
(Move to ...)
ABOUT
INDUSTRY REPORTS
WEBINARS
KEYNOTE SPEAKING
ADVERTISE
SUBSCRIBE / CONTACT
▼
Tuesday, November 19, 2024
Large Chains’ Position in 2025’s Part D Pharmacy Networks: Supermarkets Take the Lead in a Shrinking PDP Market
›
In Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market , I documented the Inflation Reduction Act’s (IRA) d...
Friday, November 15, 2024
From Integration to AI: The Data-Driven Future of Market Access
›
Today’s guest post comes from Kala Bala, SVP, Enterprise Access & Data Expertise, MMIT, a Norstella company and Dinesh Kabaleeswaran, ...
Wednesday, November 13, 2024
Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market
›
Uh oh. As I predicted, the stand-alone Medicare Part D prescription drug plans (PDP) market is vanishing. For 2025, DCI’s exclusive analysi...
Tuesday, November 12, 2024
Drug Channels Outlook 2025 (NEW Live Video Webinar)
›
Adam J. Fein, Ph.D., president of Drug Channels Institute (DCI) and the author of Drug Channels , invites you to join him for DCI’s new live...
Friday, November 08, 2024
How the Perfect Storm Will Impact Patient Support Programming in 2025 and Beyond
›
Today’s guest post comes from Chris Dowd, Senior VP of Market Development at ConnectiveRx. Chris examines three key trends that will affe...
Monday, November 04, 2024
Transparency Shocker: Biosimilars Are Getting Cheaper—But Hospitals and Insurers Can Make Them Expensive
›
Here on Drug Channels , we have long highlighted the boom in provider-administered biosimilars. In contrast to the pharmacy market, adoption...
Friday, November 01, 2024
How Field Reimbursement Services Help Overcome Coverage Barriers and Improve Patient Outcomes
›
Today’s guest post comes from Kimberley Chiang, Vice President of Biopharma Commercial Solutions at CoverMyMeds Kimberley highlghts the c...
Tuesday, October 29, 2024
Drug Channels News Roundup, October 2024: Humira Price War Update, PA vs. Providers, IRA vs. Physicians, My AI Podcast, New DCI Jobs, and Dr. G on Copayments
›
Eeek! It's time for Drug Channels’ Halloween roundup of terrifying tales to share with your ghoulish fiends. This month’s tricks and tr...
Friday, October 25, 2024
No More Delays: Accelerating Therapy Starts by Embedding Hub Services in Provider Workflows
›
Today’s guest post comes from Shabbir Ahmed, Chief Commercial Officer at CareMetx. Shabbir explains the barriers that providers face when d...
Tuesday, October 22, 2024
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
›
Reality has again failed to support the spin surrounding the 340B Drug Pricing Program. For 2023, discounted purchases under the 340B progr...
Monday, October 21, 2024
Informa Connect’s Trade and Channel Strategies
›
Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% wit...
Friday, October 18, 2024
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
›
Today’s guest post comes from Greg Skalicky, President, EVERSANA and Faruk Abdullah, President, Professional Services & Chief Business O...
›
Home
View web version